{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:16:00Z","timestamp":1787062560534,"version":"build-2736575974"},"reference-count":66,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:00:00Z","timestamp":1720224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Special Research Account of the National and Kapodistrian University of Athens","award":["20131"],"award-info":[{"award-number":["20131"]}]},{"name":"The Special Research Account of the National and Kapodistrian University of Athens","award":["15244"],"award-info":[{"award-number":["15244"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Organometallic complexes of the formula [Ru(N^N)(p-cymene)Cl][X] (N^N = bidentate polypyridyl ligands, p-cymene = 1-methyl-4-(1-methylethyl)-benzene, X = counter anion), are currently studied as possible candidates for the potential treatment of cancer. Searching for new organometallic compounds with good to moderate cytotoxic activities, a series of mononuclear water-soluble ruthenium(II)\u2013arene complexes incorporating substituted pyridine\u2013quinoline ligands, with pending -CH2OH, -CO2H and -CO2Me groups in the 4-position of quinoline ring, were synthesized, for the first time, to study their possible effect to modulate the activity of the ruthenium p-cymene complexes. These include the [Ru(\u03b76-p-cymene)(pqhyme)Cl][X] (X = Cl\u2212 (1-Cl), PF6\u2212 (1-PF6), pqhyme = 4-hydroxymethyl-2-(pyridin-2-yl)quinoline), [Ru(\u03b76-p-cymene)(pqca)Cl][Cl] ((2-Cl), pqca = 4-carboxy-2-(pyridin-2-yl)quinoline), and [Ru(\u03b76-p-cymene)(pqcame)Cl][X] (X = Cl\u2212 (3-Cl), PF6\u2212 (3-PF6), pqcame = 4-carboxymethyl-2-(pyridin-2-yl)quinoline) complexes, respectively. Identification of the complexes was based on multinuclear NMR and ATR-IR spectroscopic methods, elemental analysis, conductivity measurements, UV\u2013Vis spectroscopic, and ESI-HRMS techniques. The solid-state structures of 1-PF6 and 3-PF6 have been elucidated by single-crystal X-ray diffraction revealing a three-legged piano stool geometry. This is the first time that the in vitro cytotoxic activities of these complexes are studied. These were conducted in HEK293T (human embryonic kidney cells) and HeLa cells (cervical cancer cells) via the MTT assay. The results show poor in vitro anticancer activities for the HeLa cancer cell lines and 3-Cl proved to be the most potent (IC50 &gt; 80 \u03bc\u039c). In both cell lines, the cytotoxicity of the ligand precursor pqhyme is significantly higher than that of cisplatin.<\/jats:p>","DOI":"10.3390\/molecules29133215","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:57:45Z","timestamp":1720425465000},"page":"3215","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ruthenium p-Cymene Complexes Incorporating Substituted Pyridine\u2013Quinoline-Based Ligands: Synthesis, Characterization, and Cytotoxic Properties"],"prefix":"10.3390","volume":"29","author":[{"given":"Afroditi","family":"Kokkosi","sequence":"first","affiliation":[{"name":"Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elpida","family":"Garofallidou","sequence":"additional","affiliation":[{"name":"Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3012-8306","authenticated-orcid":false,"given":"Nikolaos","family":"Zacharopoulos","sequence":"additional","affiliation":[{"name":"Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0262-9382","authenticated-orcid":false,"given":"Nikolaos","family":"Tsoureas","sequence":"additional","affiliation":[{"name":"Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9635-2032","authenticated-orcid":false,"given":"Konstantina","family":"Diamanti","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4624-4735","authenticated-orcid":false,"given":"Nikolaos S.","family":"Thomaidis","sequence":"additional","affiliation":[{"name":"Laboratory of Analytical Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6180-821X","authenticated-orcid":false,"given":"Antigoni","family":"Cheilari","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy and Natural Products Chemistry, Faculty of Pharmacy, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Machalia","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-8270","authenticated-orcid":false,"given":"Evangelia","family":"Emmanouilidou","sequence":"additional","affiliation":[{"name":"Laboratory of Biochemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5261-5654","authenticated-orcid":false,"given":"Athanassios I.","family":"Philippopoulos","sequence":"additional","affiliation":[{"name":"Laboratory of Inorganic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis Zografou, 15771 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9069","DOI":"10.1039\/c1dt10522a","article-title":"Metal-based antitumour drugs in the post-genomic era: What comes next?","volume":"40","author":"Sava","year":"2011","journal-title":"Dalton Trans."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"D\u2019Amato, A., Mariconda, A., Iacopetta, D., Ceramella, J., Catalano, A., Sinicropi, M.S., and Longo, P. (2023). Complexes of Ruthenium(II) as Promising Dual-Active Agents against Cancer and Viral Infections. Pharmaceuticals, 16.","DOI":"10.3390\/ph16121729"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Adhikari, S., Nath, P., Das, A., Datta, A., Baildya, N., Duttaroy, A.K., and Pathak, S. (2024). A review on metal complexes and its anti-cancer activities: Recent updates from in vivo studies. Biomed. Pharmacother., 171.","DOI":"10.1016\/j.biopha.2024.116211"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Sun, Q., Li, Y., Shi, H., Wang, Y., Zhang, J., and Zhang, Q. (2021). Ruthenium Complexes as Promising Candidates against Lung Cancer. Molecules, 26.","DOI":"10.3390\/molecules26154389"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"16339","DOI":"10.1039\/D2NR02994D","article-title":"Ruthenium-based antitumor drugs and delivery systems from monotherapy to combination therapy","volume":"14","author":"Lu","year":"2022","journal-title":"Nanoscale"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.drup.2006.05.002","article-title":"DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity","volume":"9","author":"Brabec","year":"2006","journal-title":"Drug Resist. Updat."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Alessio, E. (2017). Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective. Eur. J. Inorg. Chem., 1549\u20131560.","DOI":"10.1002\/ejic.201600986"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"113011","DOI":"10.1016\/j.ccr.2019.07.008","article-title":"Chemistry and reactivity of ruthenium(II) complexes: DNA\/protein binding mode and anticancer activity are related to the complex structure","volume":"398","author":"Masnikosa","year":"2019","journal-title":"Coord. Chem. Rev."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-8545(02)00312-0","article-title":"Ruthenium metallopharmaceuticals","volume":"236","author":"Clarke","year":"2003","journal-title":"Coord. Chem. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2018.03.015","article-title":"Detailed account on activation mechanisms of ruthenium coordination complexes and their role as antineoplastic agents","volume":"150","author":"Pal","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.1021\/cr4004314","article-title":"Synthetic methods for the preparation of platinum anticancer complexes","volume":"114","author":"Wilson","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.1158\/1078-0432.CCR-03-0746","article-title":"A Phase I and pharmacological study withimidazolium-trans-DMSO-imidazole-tetrachloro ruthenate, a novel ruthenium anticancer agent","volume":"10","author":"Pluim","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/cbdv.200890195","article-title":"KP1019, A new redox-active anticancer agent\u2014Preclinical development and results of a clinical phase I study in tumor patients","volume":"5","author":"Hartinger","year":"2008","journal-title":"Chem. Biodivers."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1039\/C3SC53243G","article-title":"NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application","volume":"5","author":"Trondl","year":"2014","journal-title":"Chem. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1039\/c2cs15299a","article-title":"Ruthenium(II) polypyridyl complexes and DNA\u2014From structural probes to cellular imaging and therapeutics","volume":"41","author":"Gill","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5375","DOI":"10.2147\/DDDT.S275007","article-title":"Ruthenium Complexes as Anticancer Agents: A Brief History and Perspectives","volume":"14","author":"Lee","year":"2020","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Nongpiur, C.G.L., Verma, A.K., Singh, R.K., Ghate, M.M., Poluri, K.M., Kaminsky, W., and Kollipara, M.R. (2023). Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities. J. Inorg. Biochem., 238.","DOI":"10.1016\/j.jinorgbio.2022.112059"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1021\/acs.organomet.2c00553","article-title":"Cytotoxicity of Ruthenium(II) Arene Complexes Containing Functionalized Ferrocenyl \u03b2-Diketonate Ligands","volume":"42","author":"Allison","year":"2023","journal-title":"Organometallics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"15170","DOI":"10.1002\/chem.202002970","article-title":"New Organometallic Ruthenium (II) Compounds Synergistically Show Cytotoxic, Antimetastatic and Antiangiogenic Activities for the Treatment of Metastatic Cancer","volume":"26","author":"Wang","year":"2020","journal-title":"Chem. A Eur. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/asia.200800149","article-title":"Medicinal organometallic chemistry: Designing metal arene complexes as anticancer agents","volume":"13","author":"Peacock","year":"2008","journal-title":"Chem. Asian J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1039\/C2DT32333H","article-title":"Ruthenium(II) arene PTA (RAPTA) complexes: Impact of enantiomerically pure chiral ligands","volume":"42","author":"Kilpin","year":"2013","journal-title":"Dalton Trans."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1021\/jm050015d","article-title":"In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes","volume":"48","author":"Scolaro","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1002\/chem.201100298","article-title":"A Ruthenium Antimetastasis Agent Forms Specific Histone Protein Adducts in the Nucleosome Core","volume":"17","author":"Wu","year":"2011","journal-title":"Chem. Eur. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2533\/chimia.2007.704","article-title":"The Design of Organometallic Ruthenium Arene Anticancer Agents","volume":"61","author":"Dougana","year":"2007","journal-title":"Chimia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jorganchem.2013.09.016","article-title":"Opening the lid on piano-stool complexes: An account of ruthenium(II)-arene complexes with medicinal applications","volume":"751","author":"Nazarov","year":"2014","journal-title":"J. Organomet. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Yan, Y.K., Melchart, M., Habtemariam, A., and Dyson, P.J. (2005). Organometallic chemistry, biology and medicine: Ruthenium arene anticancer complexes. Chem. Commun., 4764\u20134776.","DOI":"10.1039\/b508531b"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"13150","DOI":"10.1021\/acs.inorgchem.8b01270","article-title":"RuII p-cymene Compounds as Effective and Selective Anticancer Candidates with No Toxicity in Vivo","volume":"57","author":"Robalo","year":"2018","journal-title":"Inorg Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jinorgbio.2016.01.005","article-title":"Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands","volume":"160","author":"Rangasamy","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1039\/B916860P","article-title":"Arene ruthenium complexes as anticancer agents","volume":"39","year":"2010","journal-title":"Dalton Trans."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"213950","DOI":"10.1016\/j.ccr.2021.213950","article-title":"Design Concepts of Half-Sandwich Organoruthenium Anticancer Agents Based on Bidentate Bioactive Ligands","volume":"445","author":"Tremlett","year":"2021","journal-title":"Coord. Chem. Rev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1039\/D0DT03107K","article-title":"DNA Targeting Half Sandwich Ru (II)-p-cymene-N,N Complexes as Cancer Cell Imaging and Terminating Agents: Influence of Regioisomers in Cytotoxicity","volume":"50","author":"Mondal","year":"2021","journal-title":"Dalton Trans."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1021\/acs.molpharmaceut.2c01027","article-title":"Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal\u2013Drug Synergism in Metallodrug Design","volume":"20","author":"Sumithaa","year":"2023","journal-title":"Mol. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jinorgbio.2016.04.008","article-title":"How half sandwich ruthenium compounds interact with DNA while not being hydrolyzed: A comparative study","volume":"160","author":"Tsolis","year":"2016","journal-title":"J. Inorg. Biochem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"215169","DOI":"10.1016\/j.ccr.2023.215169","article-title":"An overview of advancement of organoruthenium(II) complexes as prospective anticancer agents","volume":"487","author":"Bashir","year":"2023","journal-title":"Coord. Chem. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Matada, B.S., Pattanashettar, R., and Yernale, N.G. (2021). A comprehensive review on the biological interest of quinoline and its derivatives. Bioorgan. Med. Chem., 32.","DOI":"10.1016\/j.bmc.2020.115973"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1039\/D1MD00220A","article-title":"Ruthenium\u0132II)\u2013arene complexes as anti-metastatic agents, and related techniques","volume":"13","author":"Chancha","year":"2022","journal-title":"RSC Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1139\/v03-215","article-title":"Telechelic poly(-caprolactones) with tethered mixed ligand ruthenium(II) chromophores","volume":"82","author":"Farah","year":"2004","journal-title":"Can. J. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nakamoto, K. (2008). Infrared and Raman Spectra of Inorganic and Coordination Compounds: Part B: Applications in Coordination, Organometallic and Bioinorganic Chemistry, John Wiley & Sons. [6th ed.].","DOI":"10.1002\/9780470405888"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/zaac.201300142","article-title":"Synthesis, X-ray Diffraction Study, and Cytotoxicity of a Cationic p-Cymene Ruthenium Chloro Complex Containing a Chelating Semicarbazone Ligand","volume":"639","author":"Zhou","year":"2013","journal-title":"Z. Anorg. Allg. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/S1386-1425(01)00622-9","article-title":"Infrared and laser Raman studies of [Ni(II)(dppe)Cl2] and [Co(III)(dppe)2Cl2]PF6 (dppe=1,2-bis(diphenylphosphino)ethane)","volume":"58","author":"Milton","year":"2002","journal-title":"Spectrochim. Acta Part A"},{"key":"ref_42","unstructured":"Kokkosi, A. (2023). Synthesis and Characterization of Ruthenium(\u0399\u0399) Complexes of the Type Ru(p-cymene)ClL]X, where X (X = Cl\u2212, PF6\u2212) and L (L = 2,2\u2032-pyridyl-4-(hydroxymethyl)quinoline). Cell Viability Experiments of the New Compounds, on HEK293T and on HeLa Cancer Cell Lines. [Master\u2019s Thesis, National and Kapodistrian University of Athens]. Available online: https:\/\/pergamos.lib.uoa.gr\/uoa\/dl\/object\/3329312."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/ic00281a009","article-title":"Triaqua(benzene)ruthenium(II) and Triaqua(benzene)osmium(II):Synthesis, Molecular Structure and Water-Exchange Kinetics","volume":"27","author":"Hummel","year":"1988","journal-title":"Inorg. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.poly.2014.10.012","article-title":"Heteroleptic ruthenium(II) complexes of 2-(2-pyridyl)benzimidazoles: A study of catalytic efficiency towards transfer hydrogenation of acetophenone","volume":"85","author":"Dayan","year":"2015","journal-title":"Polyhedron"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11224-011-9890-0","article-title":"Half-sandwich ruthenium(II) complexes with N- and N,(N,O)-donor ligands: Molecular, electronic structures, and computational study","volume":"23","year":"2012","journal-title":"Struct. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jorganchem.2016.08.030","article-title":"Synthesis, characterisation, and properties of p-cymene Ruthenium(II) tetracarboxylate bipyridine complexes [(\u03b76-p-cymene)Ru(Rn,Rn\u2032-tcbpy)Cl][Cl]","volume":"823","author":"Woodward","year":"2016","journal-title":"J. Organomet. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4559","DOI":"10.1149\/1.1392674","article-title":"The Adsorption Behavior of a Ruthenium-Based Sensitizing Dye to Nanocrystalline TiO2 Coverage Effects on the External and Internal Sensitization Quantum Yields","volume":"146","author":"Fillinger","year":"1999","journal-title":"J. Electrochem. Soc."},{"key":"ref_48","unstructured":"Bennett, M.A., Huang, T.N., Matheson, T.W., and Smith, K. (1982). Inorganic Synthesis, John Wiley & Sons."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1080\/00958972.2016.1243238","article-title":"Synthesis, characterization, and cytotoxic and antimicrobial activities of ruthenium(II) arene complexes with N,N-bidentate ligands","volume":"69","author":"Gichumbi","year":"2016","journal-title":"J. Coord. Chem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1016\/S0277-5387(03)00460-1","article-title":"Reactivity studies of \u03b76-arene ruthenium (II) dimers with polypyridyl ligands: Isolation of mono, binuclear p-cymene ruthenium (II) complexes and bisterpyridine ruthenium (II) complexes","volume":"22","author":"Lalrempuia","year":"2003","journal-title":"Polyhedron"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1039\/C7DT00439G","article-title":"Comparative solution equilibrium studies of antitumor ruthenium(\u03b76 -p-cymene) and rhodium(\u03b75-C5Me5) complexes of 8- hydroxyquinolines","volume":"46","author":"Pape","year":"2017","journal-title":"Dalton Trans."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1080\/00958972.2010.516362","article-title":"Electrochemical studies of the bis (triphenyl phosphine) ruthenium(II) complex, cis-[RuCl2(L)(PPh3)2], with L = 2-(2\u2032-pyridyl)quinoxaline","volume":"63","author":"Tsierkezos","year":"2010","journal-title":"J. Coord. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0010-8545(00)80009-0","article-title":"The use of conductivity measurements in organic solvents for the characterisation of coordination compounds","volume":"7","author":"Geary","year":"1971","journal-title":"Coord. Chem. Rev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2010.10.031","article-title":"Synthesis and crystal structure of two new dinuclear cobalt(II) complexes interaction with HeLa cells","volume":"46","author":"Gao","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Margariti, A., Papakonstantinou, V.D., Stamatakis, G.M., Demopoulos, C.A., Machalia, C., Emmanouilidou, E., Schnakenburg, G., Nika, M.-C., Thomaidis, N.S., and Philippopoulos, A.I. (2023). First-Row Transition Metal Complexes Incorporating the 2-(2\u2032-pyridyl)quinoxaline Ligand (pqx), as Potent Inflammatory Mediators: Cytotoxic Properties and Biological Activities against the Platelet-Activating Factor (PAF) and Thrombin. Molecules, 28.","DOI":"10.3390\/molecules28196899"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Pujante-Gali\u00e1n, M.A., P\u00e9rez, S.A., Montalb\u00e1n, M.G., Carissimi, G., Fuster, M.G., V\u00edllora, G., and Garc\u00eda, G. (2020). p-Cymene Complexes of Ruthenium(II) as Antitumor Agents. Molecules, 25.","DOI":"10.3390\/molecules25215063"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Fuster, M.G., Moulefera, I., Montalb\u00e1n, M.G., P\u00e9rez, J., V\u00edllora, G., and Garc\u00eda, G. (2022). Synthesis and Characterization of New Ruthenium (II) Complexes of Stoichiometry [Ru(p-Cymene)Cl2L] and Their Cytotoxicity against HeLa-Type Cancer Cells. Molecules, 27.","DOI":"10.3390\/molecules27217264"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1021\/jm060596m","article-title":"Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands","volume":"49","author":"Habtemariam","year":"2006","journal-title":"J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Muralisankar, M., Chen, J.-R., Haribabu, J., and Ke, S.-C. (2023). Effective and Selective Ru(II)-Arene Complexes Containing 4,4\u2032-Substituted 2,2\u2032 Bipyridine Ligands Targeting Human Urinary Bladder Cancer Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241511896"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1080\/00397919708006824","article-title":"A simple preparation of a functioalized diimine ligand: 2-(2-pyridyl)-4- carboxyquinoline","volume":"27","author":"Bass","year":"1997","journal-title":"Synth. Commun."},{"key":"ref_61","unstructured":"Peppas, A. (2015). Synthesis and Characterization of Homoleptic Copper(I) Complexes. Application in Third Generation Solar Cells (Gratzel Type). [Master\u2019s Thesis, National and Kapodistrian University of Athens]. Available online: https:\/\/pergamos.lib.uoa.gr\/uoa\/dl\/object\/1320032."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.poly.2019.07.033","article-title":"Heteroleptic copper(I) complexes incorporating sterically demanding diazabutadiene ligands (DABs). Synthesis, spectroscopic characterization and solid state structural analysis","volume":"171","author":"Peppas","year":"2019","journal-title":"Polyhedron"},{"key":"ref_63","first-page":"3","article-title":"SHELXT\u2014Integrated space-group and crystal structure determination","volume":"A71","author":"Sheldrick","year":"2015","journal-title":"Acta Cryst."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1107\/S0108767307043930","article-title":"A short history of SHELX","volume":"A64","author":"Sheldrick","year":"2008","journal-title":"Acta Cryst."},{"key":"ref_65","first-page":"3","article-title":"Crystal structure refinement with SHELXL","volume":"C71","author":"Sheldrick","year":"2015","journal-title":"Acta Cryst."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: A complete structure solution, refinement, and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Cryst."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/13\/3215\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:11:07Z","timestamp":1760109067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/13\/3215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,6]]},"references-count":66,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["molecules29133215"],"URL":"https:\/\/doi.org\/10.3390\/molecules29133215","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,6]]}}}